DOP increased the levels of GLP-1, High-density lipoprotein cholesterol (HDL-C), alleviated hepatic oxidative damage and reduced hepatic steatosis by elevating the levels of superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH), and by lowering the level of MDA. The gene discussed is CAT; the disease is fatty liver disease.